There was no statistically significant differences between IL-10 −819C/T polymorphism and T2DM risk (CC/CT vs. TT: OR = 0.93, 95% CI = 0.49–1.75; Figure 2B). This evidence concerns the gene IL10 and type 2 diabetes mellitus.